- Report
- October 2024
- 195 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- June 2024
- 130 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 75 Pages
United States
From €3090EUR$3,250USD£2,596GBP
- Report
- May 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2024
- 97 Pages
Global
From €2804EUR$2,950USD£2,356GBP
- Report
- January 2021
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2023
- 109 Pages
Africa, Middle East
From €1426EUR$1,500USD£1,198GBP
- Book
- February 2021
- 252 Pages
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- February 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- November 2021
- 270 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Book
- September 2023
- 512 Pages

The Glucose Biosensors market is a subset of the larger Biotechnology industry. It is focused on the development and production of biosensors that measure glucose levels in the body. These biosensors are used in a variety of medical applications, such as diabetes management, and are becoming increasingly popular due to their accuracy and convenience. The market is driven by the increasing prevalence of diabetes and other metabolic disorders, as well as the growing demand for non-invasive glucose monitoring. Additionally, technological advancements in the field of biosensors have enabled the development of more accurate and cost-effective products.
Notable companies in the Glucose Biosensors market include Abbott Laboratories, Medtronic, Dexcom, LifeScan, and Roche Diagnostics. Show Less Read more